DENDREON TARGETING CANCER, TRANSFORMING LIVES
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Jan 2023)
What this means for you
This application is over — abandoned 16 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90260940
- Mark type
- Design + words
- Filed
- 17 Oct 2020
- Published for opposition
- 20 Apr 2021
- Abandoned
- 16 Jan 2023
Goods and services
- Class 042 — Scientific and technological services: Testing, inspection, research, or development of pharmaceutical preparations for gene therapy, immunopharmaceuticals, and vaccines; Research, development, engineering and testing services in the fields of gene therapy, immunopharmaceuticals, and vaccines
Owner
- Dendreon Pharmaceuticals LLC, Seal Beach, CA, US
- Dendreon Pharmaceuticals LLC, Seal Beach, CA, US
Prior registrations
Prosecution history
- 04 Dec 2024 — WITHDRAWAL OF ATTORNEY GRANTED
- 04 Dec 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED
- 17 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 06 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 May 2022 — SOU EXTENSION 2 GRANTED
- 04 May 2022 — SOU EXTENSION 2 FILED
- 04 May 2022 — SOU TEAS EXTENSION RECEIVED
- 17 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2021 — SOU EXTENSION 1 GRANTED
- 15 Dec 2021 — SOU EXTENSION 1 FILED
- 15 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 15 Jun 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Apr 2021 — PUBLISHED FOR OPPOSITION